Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10733334 | PMC |
| http://dx.doi.org/10.1038/s41408-023-00965-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Autologous CD19-targeting CAR-T has transformed management of relapsed/refractory adult B-cell acute lymphoblastic leukaemia(B-ALL) but relapse post-allogeneic stem cell transplant(allo-SCT) is frequently accompanied by profound lymphopenia, impaired T-cell fitness and aggressive disease requiring urgent treatment, making autologous CAR-T challenging to deliver. We developed an allogeneic matched-donor CD19CAR product (CAR-DLI) for adult B-ALL following allo-SCT failure. Here we evaluate the risks/benefits of pre-CAR-DLI lymphodepleting chemotherapy (LD), and the efficacy of repeat CAR-DLI dosing as per conventional DLI scheduling/protocols.
View Article and Find Full Text PDFRecombinant canine distemper virus expressing virus-like particle VP2 protein of mink enteritis virus protects minks against lethal challenges of both viruses.
Vet Microbiol
August 2025
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China. Electronic address:
Canine distemper virus (CDV) and mink enteritis virus (MEV) are among the most devastating viruses in minks (Mustela vison). They often cause two fatal diseases-canine distemper (CD) and mink viral enteritis (MVE)-resulting in severe respiratory symptoms and acute enteritis in breeding minks, respectively. Here, using the attenuated CDV vaccine strain CDV3-CL (currently employed in breeding mink in China) as a backbone, we constructed a recombinant strain, rCDV3-mVP2, expressing the wild-type MEV capsid protein VP2.
View Article and Find Full Text PDFSafety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults.
Vaccine
December 2024
Hope Clinic, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Article Synopsis
- Rabies remains a high-mortality disease, prompting the exploration of a novel vaccine called ChAd155-RG, which uses a genetically modified chimpanzee adenovirus vector to improve immunization logistics.
- A phase 1 clinical trial involving healthy adults compared the safety and immune response of ChAd155-RG to the standard vaccine, RabAvert, assessing factors like side effects and antibody levels.
- Results showed that while ChAd155-RG was generally safe, it demonstrated lower and less lasting antibody responses against rabies compared to RabAvert, possibly influenced by participants' preexisting immunity to the adenovirus vector used in the vaccine.
L-plastin associated syndrome of immune deficiency and hematologic cytopenia.
J Allergy Clin Immunol
September 2024
Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, Australia; Canberra Clinical Genomics, Canberra, Australia; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Ca
Article Synopsis
- LCP1 is a gene that encodes L-plastin, an actin-bundling protein important for immune cells, and its deficiency can lead to various blood and immune issues in mice and fish.
- This study investigated a specific genetic variant of LCP1 found in humans that was linked to an inherited immune deficiency, using genetic and cellular analysis on affected family members as well as engineered mouse and cell models.
- Results showed that the identified genetic mutation causes significant blood cell reductions and functional defects, highlighting a unique immune disorder marked by issues in neutrophils, lymphocytes, and platelets due to partial LCP1 deficiency.
IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy.
Biomolecules
April 2024
Radiation Oncology Unit, 1st Department of Radiology, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens (NKUOA), 11528 Athens, Greece.
The IFN-type-I pathway is involved in radiotherapy (RT)-mediated immune responses. Large RT fractions have been suggested to potently induce this pathway. Neoadjuvant hypofractionated short-course (scRT) and conventional long-course (lcRT) RT applied for the treatment of locally advanced rectal adenocarcinoma patients provides a unique model to address the immuno-stimulatory properties of RT on a systemic level.
View Article and Find Full Text PDF